SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1.85 Cr | ₹-6.26 Cr | ₹9.61 Cr | ₹0.00 Cr | ₹-0.16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SOTAC PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-1.85 Cr |
| Mar2024 | ₹-6.26 Cr |
| Mar2023 | ₹9.61 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹-0.16 Cr |
How is Net Cash Inflow / Outflow of SOTAC PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.85 Cr | Negative | |
| Mar2024 | ₹-6.26 Cr | Negative | |
| Mar2023 | ₹9.61 Cr | 192,000.00 | |
| Mar2022 | ₹0.00 Cr | Positive | |
| Mar2021 | ₹-0.16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses